Publications by authors named "M J Coppens"

Claim this Profile
F
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B.
Steven W Pipe, Wolfgang Miesbach, Michael Recht, Frank W G Leebeek, Nigel S Key, Michiel Coppens

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.
Konrad van der Zwet, Amber D W de Vos, Marjon H Cnossen, Floor C J I Heubel-Moenen, Saskia E M Schols, Michiel Coppens

J Thromb Haemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparin.
Thijs F van Haaps, Alexander P Benz, Lizhen Xu, Saskia Middeldorp, John W Eikelboom, Michiel Coppens

Res Pract Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of computed tomography venography compared with ultrasonography for detection of peripherally inserted central venous catheter-related thrombosis in patients with cancer: the DETECT study.
Noori A M Guman, Bart M van Dooremaal, Ludo F Beenen, Maeke J Scheerder, Anne-Marie Becking, Michiel Coppens

J Thromb Haemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving outcome in SubaraChnoid HEMorrhage wIth nAdroparin (ISCHEMIA): a prospective randomised controlled trial protocol.
Nadine Denneman, Tom C Doorschodt, Bert A Coert, René van den Berg, Charles B L M Majoie, Michiel Coppens

BMJ Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis